Atara Biotherapeutics Inc. | |
Stock Exchange | NASDAQ Stock Market |
EPS |
$5.62 |
Market Cap |
$914.38 M |
Shares Outstanding |
46.32 M |
Public Float |
38.75 M |
Address |
611 Gateway Boulevard South San Francisco California 94080 United States |
Employees | - |
Website | http://www.atarabio.com |
Updated | 07/08/2019 |
Atara Biotherapeutics, Inc. operates as a clinical stage company which focuses on developing novel therapeutics for serious unmet medical needs, with an initial focus on muscle wasting conditions and oncology. Its product candidates are biologics targeting myostatin and activin, members of the transforming growth factor-beta, protein superfamily, which play roles in the growth and maintenance of muscle and many other body tissues. The company was founded by Isaac E. |